Indoco Remedies Limited Indoco Remedies Limited

Indoco Remedies Limited

INDOCO

Rank in Stocks #15967
Indoco Remedies Limited, an Indian pharmaceutical company founded in Mumbai in... Indoco Remedies Limited, an Indian pharmaceutical company founded in Mumbai in 1945 (originally known as Indo Continental Trading Company), operates globally, manufacturing and distributing a broad spectrum of finished drug formulations and active pharmaceutical ingredients (APIs). The company's extensive product portfolio addresses diverse therapeutic areas: Respiratory conditions: with offerings like Karvol Plus, Febrex Plus, and Tuspel. Oral and dental care (stomatologicals): including Sensodent-K, Sensoform Toothpaste, the Rexidin series, and Snowdent. Gastrointestinal ailments: featuring products such as Carmicide, Cyclopam, and Nosic. Pain relief/analgesics: exemplified by Lignox and T-lac. Ophthalmic and otic solutions: comprising items like Renolen, Dexoren – S, and the Mofloren range. Vitamins, minerals, and nutritional supplements: such as Methycal, MCBM DHA, and Apispur. Urological treatments: including Carmicide and Cital. Dermatological preparations: like Cloben G and Scabex. Anti-infective agents: represented by ATM. Blood-related therapies: such as Hemsyl. Gynecological health products: including MCBM 69 and D Chiro. Anti-haemorrhoidal treatments: with Spear. Beyond its pharmaceutical manufacturing, Indoco Remedies provides comprehensive analytical services. These include impurity profiling, particle size analysis, heavy metal analysis, polymorphism studies, compatibility and stability assessments (like extractables/leachables and lyophilization), and advanced chromatographic method development and validation. Furthermore, the company offers a suite of engineering and project management services. This covers architectural and structural design, mechanical and electrical engineering, lighting solutions, control system integration, piping design, data transfer systems, and holistic project and construction management for process facilities. Indoco Remedies serves a wide range of medical professionals, from general practitioners and pediatricians to specialized consultants like dentists, cardiologists, diabetologists, endocrinologists, gynaecologists, and ophthalmologists.
Share Price
$2.59
Last synced: 2026-11-18
Market Cap
$225.53M
Change (1 day)
8.13%
Change (1 year)
-11.98%
Country

Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this

Trade Indoco Remedies Limited (INDOCO)

Category

Healthcare
Dividend yield history for Indoco Remedies Limited (INDOCO)
Indoco Remedies Limited (stock symbol: INDOCO) dividend yield (TTM) as of 2025: 0.66%
Average dividend yield, last 5 years : 0.50%
Dividend yield history for Indoco Remedies Limited (INDOCO) from 2004 to 2026
Dividend Yield at the end of each year (TTM)
Year Dividend Yield Change
2026 (TTM) 0.09% -86.36%
2025 0.66% 1.54%
2024 0.65% -5.80%
2023 0.69% 72.50%
2022 0.40% 263.64%
2021 0.11% -35.29%
2020 0.17% -71.67%
2019 0.60% -32.58%
2018 0.89% 709.09%
2017 0.11% -91.06%
2016 1.23% 173.33%
2015 0.45% -50.55%
2014 0.91% -56.87%
2013 2.11% -7.86%
2012 2.29% 25.14%
2011 1.83% 215.52%
2010 0.58% -91.27%
2009 6.64% 155.38%
2008 2.60% 3.17%
2007 2.52% 11.01%
2006 2.27% 0.00%
2005 0.00% -100.00%
2004 2.00% 0.00%
Dividend yields (TTM) for similar companies or competitors

Questions about Indoco Remedies Limited's dividend yield

What is Indoco Remedies Limited's dividend yield?

Indoco Remedies Limited's dividend yield is 0.09%, as of Nov 2026.

What was Indoco Remedies Limited's dividend yield in 2025?

In 2025, Indoco Remedies Limited's dividend yield was 0.66%, compared with 0.65% in 2024.

How has Indoco Remedies Limited's dividend yield changed since 2020?

From 2020 to 2025, Indoco Remedies Limited's dividend yield was highest in 2023 (0.69%) and lowest in 2021 (0.11%).

How does Indoco Remedies Limited's dividend yield compare with similar companies?

Indoco Remedies Limited's dividend yield (0.09%) is higher than that of 1 of the 5 similar companies listed above. The highest among them is Takeda Pharmaceutical Company Limited, with 2.92%.